Evidence map›Paper›PMID 12767993›Full record

ArticleJournal of virology2003

Structure-function analysis of herpes simplex virus type 1 gD and gH-gL: clues from gDgH chimeras.

Tina M Cairns, Richard S B Milne, Manuel Ponce-de-Leon, Deanna K Tobin, Gary H Cohen, Roselyn J Eisenberg

Abstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. mBio · 2021
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Tina M CairnsDepartment of Microbiology, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. tmcairns@biochem.dental.upenn.edu
Richard S B Milne
Manuel Ponce-de-Leon
Deanna K Tobin
Gary H Cohen
Roselyn J Eisenberg
University of Dental Medicine · MMUniversity of Pennsylvania · US

Funding

Studies of Herpes Simplex Virus GlycoproteinsR37AI018289 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COHEN, GARY H · 2005 to 2014
$3.9M
STUDIES OF HERPES SIMPLEX VIRUS GLYCOPROTEINSR01AI018289 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COHEN, GARY H · 1985 to 2019
$3.8M
PATHOGNESIS OF MOUSE HEPATITIS CORONAVIRUSP01NS030606 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI GONZALEZ-SCARANO, FRANCISCO A · 1993 to 2002
$3.2M
EARLY EVENTS IN HERPES SIMPLEX VIRUS ENTRYR01NS036731 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI EISENBERG, ROSELYN J · 1997 to 2006
$2.4M
NIAID NIH HHS AI-18289NIAID NIH HHS R01 AI018289NIAID NIH HHS R37 AI018289NINDS NIH HHS NS30606NINDS NIH HHS NS36731NINDS NIH HHS P01 NS030606NINDS NIH HHS R01 NS036731
6 · The paper itself

Abstract

In alphaherpesviruses, glycoprotein B (gB), gD, gH, and gL are essential for virus entry. A replication-competent gL-null pseudorabies virus (PrV) (B. G. Klupp and T. C. Mettenleiter, J. Virol. 73:3014-3022, 1999) was shown to express a gDgH hybrid protein that could replace gD, gH, and gL in cell-cell fusion and null virus complementation assays. To study this phenomenon in herpes simplex virus type 1 (HSV-1), we constructed four gDgH chimeras, joining the first 308 gD amino acids to various gH N-terminal truncations. The chimeras were named for the first amino acid of gH at which each was truncated: 22, 259, 388, and 432. All chimeras were immunoprecipitated with both gD and gH antibodies to conformational epitopes. Normally, transport of gH to the cell surface requires gH-gL complex formation. Chimera 22 contains full-length gH fused to gD308. Unlike PrV gDgH, chimera 22 required gL for transport to the surface of transfected Vero cells. Interestingly, although chimera 259 failed to reach the cell surface, chimeras 388 and 432 exhibited gL-independent transport. To examine gD and gH domain function, each chimera was tested in cell-cell fusion and null virus complementation assays. Unlike PrV gDgH, none of the HSV-1 chimeras substituted for gL for fusion. Only chimera 22 was able to replace gH for fusion and could also replace either gH or gD in the complementation assay. Surprisingly, this chimera performed very poorly as a substitute for gD in the fusion assay despite its ability to complement gD-null virus and bind HSV entry receptors (HveA and nectin-1). Chimeras 388 and 432, which contain the same portion of gD as that in chimera 22, substituted for gD for fusion at 25 to 50% of wild-type levels. However, these chimeras functioned poorly in gD-null virus complementation assays. The results highlight the fact that these two functional assays are measuring two related but distinct processes.

Indexed as

AnimalsCell Adhesion MoleculesCell FusionCell LineChlorocebus aethiopsHerpesvirus 1, HumanHumansNectinsPrecipitin TestsReceptors, Tumor Necrosis FactorReceptors, Tumor Necrosis Factor, Member 14Receptors, VirusRecombinant Fusion ProteinsStructure-Activity RelationshipVero CellsViral Envelope ProteinsCell Adhesion Moleculesglycoprotein D, Human herpesvirus 1glycoprotein H, herpes simplex virus type 1glycoprotein L, Human herpesvirus 1NECTIN1 protein, humanNectinsReceptors, Tumor Necrosis FactorReceptors, Tumor Necrosis Factor, Member 14Receptors, VirusRecombinant Fusion ProteinsTNFRSF14 protein, humanViral Envelope Proteins

Identifiers

PMID12767993
PMCPMC156167
OpenAlexW2118442949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.